Roche
Swiss Re helps Roche open up China’s oncology market
December 17, 2012Sales and Marketing Cancer, China, Roche, Swiss re, oncology
Roche and reinsurance firm Swiss Re have teamed up to find an innovative way into China’s healthcare market. For the …
Roche plans €200m investment in diagnostics facility
December 12, 2012Manufacturing and Production Diagnostics, Roche
Roche has said it intends to invest more than €200 million ($260m) in the construction of a new production plant …
Perjeta reduces risk of death
December 11, 2012Sales and Marketing Cancer, Perjeta, Roche
Roche’s cancer drug Perjeta helps reduce the risk of death by 34% in patients with HER2-positive metastatic breast cancer (mBC), …
Alzheimer’s drug lowers mortality
December 7, 2012Sales and Marketing Alzheimer's, Janssen, Razadyne, Roche, lilly
A study of Janssen Pharmaceuticals’ Razadyne suggests that the Alzheimer’s drug helped patients stay alive longer and slowed their cognitive …
Roche to release Tamiflu data
November 23, 2012Sales and Marketing BMJ, Cochrane, Goldacre, NHS, Roche, Tamiflu
Roche has said it will let researchers have access to more data on its influenza vaccine Tamiflu, apparently under pressure …
Avastin shows brain cancer benefit
November 20, 2012Research and Development, Sales and Marketing Cancer, FDA, Merck, Roche, avastin, brain
In a Phase III trial, Roche’s Avastin has helped people with newly-diagnosed glioblastoma (GBM) live longer without their disease worsening. …
NICE hails ‘breakthrough’ skin cancer treatments
November 2, 2012Sales and Marketing BMS, NICE, Roche, Yervoy, Zelboraf
Two new skin cancer drugs have been recommended by NICE, which hailed the drugs as ‘breakthrough treatments’. Bristol-Myers Squibb’s Yervoy …
Roche sees Q3 sales rise
October 16, 2012Sales and Marketing Roche, financials
Roche’s sales for January to September this year were up 4% on the same nine-month period in 2011, with oncology …
New drugs for Alzheimer’s trial
October 15, 2012Research and Development, Sales and Marketing Alzheimer's, Roche, lilly
Roche and Eli Lilly are providing drugs free of charge to US investigators conducting a worldwide trial of Alzheimer’s disease …
Scotland ‘no’ to Avastin
October 9, 2012Sales and Marketing NICE, Roche, Scotland, avastin
Roche has slammed the Scottish Medicines Consortium (SMC)’s decision not to recommend Avastin for women with advanced ovarian cancer in …
NICE does Lucentis U-turn
October 5, 2012Sales and Marketing Lucentis, NICE, Novartis, Roche, avastin
NICE has done a U-turn over its previous verdict on Novartis’ Lucentis, now recommending the drug in draft guidance to …
Is it really safety first?
October 2, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Les Rose, Roche
The idea of ensuring that drugs are adequately safe is not very old. Legislation that covers drug safety to the …
BMS highlights Yervoy survival data
October 1, 2012Research and Development, Sales and Marketing BMS, Roche, Yervoy, Zelboraf
Bristol-Myers Squibb’s melanoma drug Yervoy helps patients survive for longer than if they are receiving standard chemotherapy alone, according to …
FDA approves Bayer’s Stivarga
October 1, 2012Research and Development, Sales and Marketing Bayer, FDA, KRAS, Roche, Stivarga, avastin
The FDA has approved Bayer HealthCare’s oncology pill Stivarga to treat patients with metastatic colorectal cancer (mCRC) whose disease has …
Roche unveils New York research base
September 26, 2012Research and Development New York, Nutley, Roche, translational research
Roche is to locate a new translational clinical research centre in central New York, as part of a shift towards …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
